Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE1435.0061.6 (+4.49 %)

PREV CLOSE ( ) 1373.40

OPEN PRICE ( ) 1419.95

BID PRICE (QTY) 1431.00 (1)

OFFER PRICE (QTY) 1438.00 (1)

VOLUME 2054

TODAY'S LOW / HIGH ( )1381.00 1442.05

52 WK LOW / HIGH ( )962.7 2774.4

NSE1435.9068.3 (+4.99 %)

PREV CLOSE( ) 1367.60

OPEN PRICE ( ) 1415.00

BID PRICE (QTY) 1425.40 (1)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2162

TODAY'S LOW / HIGH( ) 1404.30 1435.90

52 WK LOW / HIGH ( )957 2777.95

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981

Management Info

Dhananjay Mungale - Chairman Rahul J Nachane - Managing Director

Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 40842222

Email cs@nglfinechem.com

Website www.nglfinechem.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE, NSE

NEWS

10Jul NGL Fine Chem informs about compliance
NGL Fine Chem has informed that it enclosed compliance certificate under..

27Jun NGL Fine-Chem informs about credit rat
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

19Apr NGL Fine Chem informs about disclosure
NGL Fine Chem has informed that NGL Fine-Chem is not falling under the c..

06Mar NGL Fine-Chem informs about outcome of
NGL Fine-Chem has informed that the fourth Meeting of the Board of Direc..

06Mar Ngl Fine-Chem informs about credit rat
Ngl Fine-Chem has informed that the Company has received rating from ICR..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	-5.19999999999994	181.32
Gross Profit	-3.59999999999994	238.82
Operating Profit	31.1900000000001	354.59
Net Sales	930.18	3592.94

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

SMS Lifesciences (BSE) 1316.40 (15.09%)	M.Cap ( in Cr)397.99
Sanofi Cons. Health (BSE) 5223.95 (1.92%)	M.Cap ( in Cr)12031.08
Procter&Gamble Healt (BSE) 5954.25 (1.53%)	M.Cap ( in Cr)9883.69
Alkem Laboratories (BSE) 5000.00 (1.35%)	M.Cap ( in Cr)59782.50
Gland Pharma (BSE) 1960.50 (3.40%)	M.Cap ( in Cr)32300.50

Shareholding Pattern

	PROMOTERS	72.74%
	NON-INSTITUTION	27.26%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.01
Motilal Oswal BSE H...	0.01

Risk Disclosures on Derivatives

Smart Quotes

NGL FINE-CHEM LTD.